Efficacy of Valsartan versus enalapril in lowering Proteinuria in patients with diabetic nephropathy.

Objective: To compare the effectiveness of valsartan and enalapril in reducing proteinuria in diabetic nephropathy patients. Study Design: Randomized Controlled Trial. Setting: Medical Floor, Allied Hospital. Period: January 3, 2024, to January 9, 2024 (Six Months). Methods: The study involved patients enrolled after approval from the Institutional Ethical Review Committee at Punjab Medical College, Faisalabad. Participants were randomly divided into two groups: Group A received valsartan 80mg daily, and Group B received enalapril 10mg daily for 3 months. Patients were monitored for efficacy after 3 months. Results: Results show no significant difference between the efficacy of the two drugs, but validation through multicenter studies is needed. Conclusion: